...
首页> 外文期刊>Bulletin of experimental biology and medicine >Proliferative activity of cadriomyocytes in chronic hypercholesterolemia
【24h】

Proliferative activity of cadriomyocytes in chronic hypercholesterolemia

机译:慢性高胆固醇血症中巨细胞的增殖活性

获取原文
获取原文并翻译 | 示例

摘要

We studied proliferative activity of cardiomyocytes (using proliferation marker Ki-67) and compared it with their total number in the heart under conditions of experimental chronic hypercholesterolemia and its combination with hypothyroidism. It was found that Ki-67-positive cells are primarily located in the subepicardial layer near the heart base in both intact and experimental animals. Replicative cardiomyocyte pool in intact rats constituted 1.67∈±∈0.33‰ of the total cardiomyocyte population; after 68-day atherogenic diet with exogenous cholesterol alone, the replicative cardiomyocyte pool decreased by 16 % (to 1.40∈±∈0.24‰). Treatment with mercazolil against the background of exogenous cholesterol increased this parameter by 40 % (to 2.33∈±∈0.88‰). Changes in replicative activity of cardiomyocytes correlated with their total number in the heart and organ weight. We conclude that replicative cardiomyocyte pool primarily includes non-terminally differentiated cardiomyocytes (small mononuclear cardiomyocytes) and their proliferation maintains the total number of cardiomyocytes in the heart under conditions of cytopathic influences and provides the basis for physiological and reparative regeneration of the myocardium.
机译:我们研究了心肌细胞的增殖活性(使用增殖标记Ki-67),并将其与实验性慢性高胆固醇血症及其合并甲状腺功能减退的条件下的心脏中的总数进行比较。已经发现,在完整动物和实验动物中,Ki-67阳性细胞主要位于心底附近的心外膜下层。完整大鼠中的复制性心肌细胞池占心肌细胞总数的1.67ε±ε0.33‰。单独使用外源胆固醇的动脉粥样硬化饮食68天后,复制性心肌细胞池减少了16%(降至1.40ε±ε0.24‰)。在外源性胆固醇的背景下用巯基唑治疗可使该参数增加40%(至2.33ε±ε0.88‰)。心肌细胞复制活性的变化与其在心脏和器官重量中的总数有关。我们得出的结论是,复制性心肌细胞池主要包括非终末分化的心肌细胞(小的单核心肌细胞),它们的增殖在细胞病变影响的情况下维持了心脏中心肌细胞的总数,并为心肌的生理和修复性再生提供了基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号